Articles Published in 2007

Top Stories for the Week of August 6th 2007

Friday, August 10, 2007 07:11 AM

Top News

More... »

Quest Diagnostics

Kendle Service Revenue Jumps

Tuesday, August 7, 2007 05:13 PM

Cincinnati-based CRO Kendle reported nearly a 60% jump in service revenue during the second quarter of 2007 compared with last year’s same period. The company had net revenue of $97.8 million for the quarter compared with $62.1 million in 2006. Kendle reported second quarter earnings per share of $.29 and total income from operations of $10.9 million.

More... »


Pfizer HIV Treatment Sees Positive Results

Monday, August 6, 2007 06:24 AM

Pfizer reported positive results from a phase III trial of maraviroc for the treatment of HIV. This 48-week trial was dubbed MERIT (maraviroc versus Efavirenz Regimens as Initial Therapy) and enrolled CCR5-tropic HIV-1 infected subjects who had never received antiretroviral therapy and had no evidence of resistance to the drugs used in the study. MERIT was designed to compare maraviroc (300 mg twice daily) to efavirenz, standard of care, (600 mg once daily), both dosed in combination with zidovudine/lamivudine.

More... »

Top Stories for the Week of July 30th 2007

Friday, August 3, 2007 09:12 AM

Top News

More... »

China and India Join WHO Registry Database

Wednesday, August 1, 2007 06:07 AM

China and India have joined a World Health Organization (WHO)-run international database of clinical trials. Both countries had already recently established their own databases but had to align those registries with a set of standard criteria set forth by a team of experts at the United Nations.

More... »

Mozibil Increases Stem Cell Count in Phase III Trials

Tuesday, July 31, 2007 07:39 AM

Genzyme reported positive results from a phase III trial of Mozobil (plerixa), a CXCR4 chemokine antagonist, as an agent for increasing the number of hematopoietic stem cells collected for stem cell transplantation procedures for the treatment of various cancers.

More... »

PRA International Agrees to Genstar Capital Buyout

Monday, July 30, 2007 06:12 AM

In a move that will take Reston, Va.-based contract research organization (CRO) PRA International off the public market, the company has entered into an agreement to be purchased by Genstar Capital, a private equity group based in San Francisco. The deal is valued at $790 million.

More... »

Top Stories for the Week of July 23rd 2007

Friday, July 27, 2007 07:23 AM

Top News

More... »

Phase Forward Revenue, Profits Jump

Wednesday, July 25, 2007 10:10 AM

Waltham, Mass.-based Phase Forward, a provider of electronic data capture (EDC), drug safety and data management solutions for clinical trials, reported second quarter revenues rose 28% to $31.5 million and profits doubled.

More... »

Serbia Celebrates International Clinical Trials Day; Clinical Center of Serbia Joins ECRIN

Tuesday, July 24, 2007 09:00 AM

By Dragana Maca Kastratovic, M.D.

More... »

`

CWWeekly

March 30

Icon, Carnegie Mellon partner to research ways to improve study patients' understanding of Informed Consent

Veeva launches OpenKey, partner program to unlock difficult access to, restrictions on customer reference data

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

April

PSI, INC Research, Chiltern best with sites
Strategic outsourcing prioritizing, improving site relationships

Regulatory compliance an increasing burden on sites
Increased staff time, materials, storage eroding site operating profit

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

March

Novo Nordisk, Takeda, Servier, Celgene among top sponsors
New gains seen from patient- and site-centric initiatives

Patient reported outcomes take center stage
FDA combining PROs, clinical outcomes in its approval decisions

Already a subscriber?
Log in to your digital subscription.

Purchase the February issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs